Allergic respiratory disease
MONDO:0000771A respiratory system disease with a basis in a pathological type I hypersensitivity reaction.
Also known as: allergic form of respiratory system disease, allergic respiratory system disease
227 clinical trials for this condition and its sub-types, 2 tagged with Allergic respiratory disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Allergic respiratory disease
-
Allergic rhinitis 97 trials · 142 incl. sub-types
3 sub-types
- Seasonal allergic rhinitis 46 trials
- Perennial allergic rhinitis 28 trials
- Vasomotor rhinitis 5 trials
-
Allergic asthma 41 trials
1 sub-type
- Isocyanate induced asthma 0 trials
-
Hypersensitivity pneumonitis 25 trials · 30 incl. sub-types
14 sub-types
- Fibrotic hypersensitivity pneumonitis 9 trials
- Ventilation pneumonitis 2 trials
- Bird fancier's lung 1 trial
- Non-fibrotic hypersensitivity pneumonitis 1 trial
- Bagassosis 0 trials
- Cork-handlers' disease 0 trials
- Farmer's lung disease 0 trials
- House allergic alveolitis 0 trials
- Hypersensitivity pneumonitis, familial 0 trials
- Idiopathic chronic eosinophilic pneumonia 0 trials
- Malt worker's lung 0 trials
- Maple bark strippers' lung 0 trials
- Mushroom workers' lung 0 trials
- Sick building syndrome 0 trials
-
Allergic bronchopulmonary aspergillosis 15 trials
1 sub-type
- Malt worker's lung 0 trials
-
Asthma drug trial halted midway: what it means for patients
Disease control Stopped earlyThis study tested a daily pill called dexpramipexole in 654 people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce severe asthma attacks over a year. However, the trial was terminat…
Phase 3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Asthma drug trial halted: Dexpramipexole's promise unfulfilled
Disease control Stopped earlyThis Phase 3 trial tested dexpramipexole, an oral drug, in over 1,000 people with severe eosinophilic asthma that was not well controlled by standard treatments. The goal was to see if it could reduce severe asthma attacks over a year. However, the study was terminated early, so …
Phase 3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Experimental asthma drug briquilimab fails to reach Late-Stage testing
Disease control Stopped earlyThis Phase 1 trial tested a single dose of briquilimab in 17 adults with mild-to-moderate allergic asthma to see if it was safe and could reduce asthma attacks triggered by allergens. The study was terminated early, meaning it did not continue as planned. The main goal was to che…
Phase 1 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:40 UTC
-
Hay fever education trial fizzles out: did extra lessons help?
Symptom relief Stopped earlyThis study tested whether teaching teens and young adults (ages 14-29) the correct way to use nasal sprays for hay fever would improve their symptoms compared to standard care. The trial was terminated early and enrolled only 18 participants. The goal was to see if repeat educati…
Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New lung camera could replace needle biopsies
Knowledge-focused Stopped earlyThis study aimed to see if a tiny camera on a thin tube (bronchoscopy) could help doctors diagnose diffuse lung diseases without needing a surgical lung biopsy. The camera takes live microscopic images of the air sacs. The study was stopped early, but it involved 38 adults with c…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Preterm Kids' lungs under the microscope: study halted early
Knowledge-focused Stopped earlyThis study aimed to track lung function in children born prematurely (before 37 weeks) aged 3 to 5 years, comparing them to full-term children. Researchers used breathing tests and samples to look for early signs of asthma and allergies. The study was terminated early, so results…
Sponsor: Stefania La Grutta, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC